Ignite Creation Date:
2025-12-24 @ 4:18 PM
Ignite Modification Date:
2026-02-25 @ 6:58 PM
Study NCT ID:
NCT06524466
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-29
First Post:
2024-07-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant SBRT Combined With Lenvatinib and Pucotenlimab for Resectable Hepatocellular Carcinoma
Sponsor:
Sun Yat-sen University
Organization: